Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/9/24 09:15 | 10/8/24 | ASMB | Health | Drug | Pharmaceutical Preparations | Schornstein Alexander | 2M | T | P | 146 | 14.58 | 0 | 10 | 1 | 703 | D | |||||||||||||||
7/8/24 10:48 | 7/3/24 | ASMB | Health | Drug | Pharmaceutical Preparations | Schornstein Alexander | 2M | T | P.m | 112 | 12.40 | 0 | 9 | 1 | 693 | D | |||||||||||||||
6/20/24 20:31 | 6/17/24 | ASMB | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P.d | 0 | 0.00 | 0 | 180 | 16 | 1,269 | D | |||||||||||||||
1/19/24 11:01 | 1/17/24 | ASMB | Health | Drug | Pharmaceutical Preparations | Schornstein Alexander | 2M | T | P.m | 511 | 0.7926 | 0 | 645 | 9 | 8,209 | D | |||||||||||||||
11/22/23 16:10 | 11/20/23 | ASMB | Health | Drug | Pharmaceutical Preparations | Schornstein Alexander | 2M | T | P.m | 282 | 0.7053 | 0 | 400 | 6 | 7,564 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |